Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies

BACKGROUND: Chimeric antigen receptor T-cell (CAR-T) cell therapies have been claimed to be curative in responsive patients. Nonetheless, response rates can vary according to different characteristics, and these therapies are associated with important adverse events such as cytokine release syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiz, Luis Carlos, Leache, Leire, Gutiérrez-Valencia, Marta, Erviti, Juan, Rojas Reyes, María Ximena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150428/
https://www.ncbi.nlm.nih.gov/pubmed/37138698
http://dx.doi.org/10.1177/20406207231168211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150428/
https://www.ncbi.nlm.nih.gov/pubmed/37138698
http://dx.doi.org/10.1177/20406207231168211

Ejemplares similares